Join us for the Dallas Myeloma Round Table at the The Statler Hotel Dallas, Nov 2nd from 9:00 am-2:30 pm CST to hear from top myeloma researchers. The day includes informative and engaging presentations about the latest in myeloma as well as breakout sessions for both newly diagnosed and relapsed/refractory patients. The event will feature two sessions that include extensive Q&A. Registration opens at 8:00 am.
If you can't make the meeting in person, please register to watch the recording. We will send an email out to all recording registrants about a week following the live meeting.
If you are traveling to the meeting and would like to make a weekend of it while you are in Dallas, here are some suggestions:
For questions about registration, contact us at +1-800-709-1113 or support@healthtree.org
For all other questions, contact Elisabeth at elisabeth@healthtree.org
Join us for the Dallas Myeloma Round Table at the The Statler Hotel Dallas, Nov 2nd from 9:00 am-2:30 pm CST to hear from top myeloma researchers. The day includes informative and engaging presentations about the latest in myeloma as well as breakout sessions for both newly diagnosed and relapsed/refractory patients. The event will feature two sessions that include extensive Q&A. Registration opens at 8:00 am.
If you can't make the meeting in person, please register to watch the recording. We will send an email out to all recording registrants about a week following the live meeting.
If you are traveling to the meeting and would like to make a weekend of it while you are in Dallas, here are some suggestions:
For questions about registration, contact us at +1-800-709-1113 or support@healthtree.org
For all other questions, contact Elisabeth at elisabeth@healthtree.org
about the author
Audrey Burton-Bethke
Audrey is a content writer and editor for the HealthTree Foundation. She originally joined the HealthTree Foundation in 2020. Audrey loves spending time with her supportive husband, energetic four-year-old, and new baby.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.